Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Biologic Trials

Boston, Massachusetts

Colorectal cancer biologic therapy trials in Boston, MA

6 colorectal cancer biologic therapy studies are recruiting participants at sites in Boston as of November 18, 2026, according to ClinicalTrials.gov. Colorectal Biologic Trials can help you understand your options and connect with a study team.

Call (888) 413-6546
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Boston at a glance

  • 6 studies are recruiting at a site in Boston.
  • By phase: Phase 1 (4), Phase 1/2 (1), Phase 3 (1).
  • By sponsor: industry (6).
  • Most recent update to one of these records: October 8, 2026.

Studies recruiting in Boston

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Brigham and Women's Hospital (BWH) · Dana-Farber Cancer Institute (DFCI)
    Registry record
    NCT07222800 · updated
  2. A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Dispatch Biotherapeutics
    Study site
    Dana-Farber Cancer Institute
    Registry record
    NCT07544589 · updated
  3. A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT05877599 · updated
  4. A Study of MGC028 in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    MacroGenics
    Study sites
    Dana Farber/Harvard Cancer Center · Mass General Brigham
    Registry record
    NCT06723236 · updated
  5. This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Zumutor Biologics Inc.
    Study site
    Dana Farber Cancer Institute
    Registry record
    NCT06451497 · updated
  6. A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    GV20 Therapeutics
    Study site
    Massachusetts General Hospital
    Registry record
    NCT05669430 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Boston, MA on ClinicalTrials.gov.

Ask about studies near Boston

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry.

Colorectal Biologic Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 413-6546

or send a short form

How should we reach you?

Call